Open Access

mAbs

, volume 8 , issue 7 , pages 1407-1416

The underlying inflammatory chronic disease influences infliximab pharmacokinetics

Christophe Passot ^{1, 2}

Denis Mulleman ^{1, 3}

Theodora Bejan-Angoulvant ^{1, 4}

Alexandre Aubourg ⁵

Stéphanie Willot ⁶

Thierry Lecomte ^{1, 5}

Laurence Picon ⁵

Philippe Goupille ^{1, 3}

Gilles Paintaud ^{1, 2}

David Ternant ^{1, 2}

Hide authors affiliations Show authors affiliations: 6 affiliations

Université François Rabelais de Tours, CNRS, UMR, “Genetics, Immunotherapy, Chemistry and Cancer,” Tours, France |

Laboratoire de Pharmacologie-Toxicologie, Tours, France |

Service de Rhumatologie, Tours, France |

⁴

Service de Pharmacologie Clinique, Tours, France |

⁵

Service de Gastro-entérologie, Tours, France |

⁶

Service de pédiatrie, Tours, France |

Publication type: Journal Article

Publication date: 2016-09-02

Taylor & Francis

mAbs

scimago Q1

wos Q1

SJR: 2.699

CiteScore: 11.7

Impact factor: 7.3

ISSN: 19420862, 19420870

DOI: 10.1080/19420862.2016.1216741

Copy DOI

PubMed ID: 27589009

Immunology

Immunology and Allergy

Found

Top-30

Journals

	1 2 3 4 5 6 7
Clinical Pharmacokinetics	Clinical Pharmacokinetics, 7, 11.48% Clinical Pharmacokinetics 7 publications, 11.48%
British Journal of Clinical Pharmacology	British Journal of Clinical Pharmacology, 6, 9.84% British Journal of Clinical Pharmacology 6 publications, 9.84%
Pharmaceutics	Pharmaceutics, 4, 6.56% Pharmaceutics 4 publications, 6.56%
CPT: Pharmacometrics and Systems Pharmacology	CPT: Pharmacometrics and Systems Pharmacology, 3, 4.92% CPT: Pharmacometrics and Systems Pharmacology 3 publications, 4.92%
Therapeutic Drug Monitoring	Therapeutic Drug Monitoring, 2, 3.28% Therapeutic Drug Monitoring 2 publications, 3.28%
Journal of Clinical Medicine	Journal of Clinical Medicine, 2, 3.28% Journal of Clinical Medicine 2 publications, 3.28%
BioDrugs	BioDrugs, 2, 3.28% BioDrugs 2 publications, 3.28%
Clinical Pharmacology and Therapeutics	Clinical Pharmacology and Therapeutics, 2, 3.28% Clinical Pharmacology and Therapeutics 2 publications, 3.28%
Clinical Pharmacology in Drug Development	Clinical Pharmacology in Drug Development, 2, 3.28% Clinical Pharmacology in Drug Development 2 publications, 3.28%
Inflammatory Bowel Diseases	Inflammatory Bowel Diseases, 2, 3.28% Inflammatory Bowel Diseases 2 publications, 3.28%
RMD Open	RMD Open, 2, 3.28% RMD Open 2 publications, 3.28%
American Journal of Gastroenterology	American Journal of Gastroenterology, 1, 1.64% American Journal of Gastroenterology 1 publication, 1.64%
European Journal of Gastroenterology and Hepatology	European Journal of Gastroenterology and Hepatology, 1, 1.64% European Journal of Gastroenterology and Hepatology 1 publication, 1.64%
Cells	Cells, 1, 1.64% Cells 1 publication, 1.64%
Frontiers in Medicine	Frontiers in Medicine, 1, 1.64% Frontiers in Medicine 1 publication, 1.64%
Drugs in R and D	Drugs in R and D, 1, 1.64% Drugs in R and D 1 publication, 1.64%
Clinical Rheumatology	Clinical Rheumatology, 1, 1.64% Clinical Rheumatology 1 publication, 1.64%
JID Innovations	JID Innovations, 1, 1.64% JID Innovations 1 publication, 1.64%
PLoS ONE	PLoS ONE, 1, 1.64% PLoS ONE 1 publication, 1.64%
Reumatología Clínica (English Edition)	Reumatología Clínica (English Edition), 1, 1.64% Reumatología Clínica (English Edition) 1 publication, 1.64%
Reumatologia Clinica	Reumatologia Clinica, 1, 1.64% Reumatologia Clinica 1 publication, 1.64%
Alimentary Pharmacology and Therapeutics	Alimentary Pharmacology and Therapeutics, 1, 1.64% Alimentary Pharmacology and Therapeutics 1 publication, 1.64%
JGH Open	JGH Open, 1, 1.64% JGH Open 1 publication, 1.64%
Journal of Crohn's and Colitis	Journal of Crohn's and Colitis, 1, 1.64% Journal of Crohn's and Colitis 1 publication, 1.64%
Expert Review of Clinical Pharmacology	Expert Review of Clinical Pharmacology, 1, 1.64% Expert Review of Clinical Pharmacology 1 publication, 1.64%
Open Access Rheumatology: Research and Reviews	Open Access Rheumatology: Research and Reviews, 1, 1.64% Open Access Rheumatology: Research and Reviews 1 publication, 1.64%
JAMA - Journal of the American Medical Association	JAMA - Journal of the American Medical Association, 1, 1.64% JAMA - Journal of the American Medical Association 1 publication, 1.64%
Saudi Journal of Gastroenterology	Saudi Journal of Gastroenterology, 1, 1.64% Saudi Journal of Gastroenterology 1 publication, 1.64%
eLife	eLife, 1, 1.64% eLife 1 publication, 1.64%
Frontiers in Cardiovascular Medicine	Frontiers in Cardiovascular Medicine, 1, 1.64% Frontiers in Cardiovascular Medicine 1 publication, 1.64%
	1 2 3 4 5 6 7

Publishers

	2 4 6 8 10 12 14 16
Wiley	Wiley, 16, 26.23% Wiley 16 publications, 26.23%
Springer Nature	Springer Nature, 12, 19.67% Springer Nature 12 publications, 19.67%
MDPI	MDPI, 7, 11.48% MDPI 7 publications, 11.48%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 5, 8.2% Ovid Technologies (Wolters Kluwer Health) 5 publications, 8.2%
Elsevier	Elsevier, 5, 8.2% Elsevier 5 publications, 8.2%
Oxford University Press	Oxford University Press, 4, 6.56% Oxford University Press 4 publications, 6.56%
Frontiers Media S.A.	Frontiers Media S.A., 3, 4.92% Frontiers Media S.A. 3 publications, 4.92%
Taylor & Francis	Taylor & Francis, 3, 4.92% Taylor & Francis 3 publications, 4.92%
BMJ	BMJ, 2, 3.28% BMJ 2 publications, 3.28%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 1, 1.64% Public Library of Science (PLoS) 1 publication, 1.64%
American Medical Association (AMA)	American Medical Association (AMA), 1, 1.64% American Medical Association (AMA) 1 publication, 1.64%
eLife Sciences Publications	eLife Sciences Publications, 1, 1.64% eLife Sciences Publications 1 publication, 1.64%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 1.64% Cold Spring Harbor Laboratory 1 publication, 1.64%
	2 4 6 8 10 12 14 16

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

PDF

Metrics

Cite this

GOST |

Cite this

GOST Copy

Passot C. et al. The underlying inflammatory chronic disease influences infliximab pharmacokinetics // mAbs. 2016. Vol. 8. No. 7. pp. 1407-1416.

GOST all authors (up to 50) Copy

Passot C., Mulleman D., Bejan-Angoulvant T., Aubourg A., Willot S., Lecomte T., Picon L., Goupille P., Paintaud G., Ternant D. The underlying inflammatory chronic disease influences infliximab pharmacokinetics // mAbs. 2016. Vol. 8. No. 7. pp. 1407-1416.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1080/19420862.2016.1216741

UR - https://doi.org/10.1080/19420862.2016.1216741

TI - The underlying inflammatory chronic disease influences infliximab pharmacokinetics

T2 - mAbs

AU - Passot, Christophe

AU - Mulleman, Denis

AU - Bejan-Angoulvant, Theodora

AU - Aubourg, Alexandre

AU - Willot, Stéphanie

AU - Lecomte, Thierry

AU - Picon, Laurence

AU - Goupille, Philippe

AU - Paintaud, Gilles

AU - Ternant, David

PY - 2016

DA - 2016/09/02

PB - Taylor & Francis

SP - 1407-1416

IS - 7

VL - 8

PMID - 27589009

SN - 1942-0862

SN - 1942-0870

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2016_Passot,

author = {Christophe Passot and Denis Mulleman and Theodora Bejan-Angoulvant and Alexandre Aubourg and Stéphanie Willot and Thierry Lecomte and Laurence Picon and Philippe Goupille and Gilles Paintaud and David Ternant},

title = {The underlying inflammatory chronic disease influences infliximab pharmacokinetics},

journal = {mAbs},

year = {2016},

volume = {8},

publisher = {Taylor & Francis},

month = {sep},

url = {https://doi.org/10.1080/19420862.2016.1216741},

number = {7},

pages = {1407--1416},

doi = {10.1080/19420862.2016.1216741}

}

MLA

Cite this

MLA Copy

Passot, Christophe, et al. “The underlying inflammatory chronic disease influences infliximab pharmacokinetics.” mAbs, vol. 8, no. 7, Sep. 2016, pp. 1407-1416. https://doi.org/10.1080/19420862.2016.1216741.

Publisher

Taylor & Francis

Journal

mAbs

scimago Q1

wos Q1

SJR

2.699

CiteScore

11.7

Impact factor

7.3

ISSN

19420862 (Print)

19420870 (Electronic)